Lessons learned from BRCA1 and BRCA2

被引:131
|
作者
Zheng, L [1 ]
Li, S [1 ]
Boyer, TG [1 ]
Lee, WH [1 ]
机构
[1] Univ Texas, Hlth Sci Ctr, Inst Biotechnol, Dept Mol Med, San Antonio, TX 78245 USA
基金
美国国家卫生研究院;
关键词
BRCA1; BRCA2; breast cancer; tumor suppressor; transcription regulation; DNA damage repair;
D O I
10.1038/sj.onc.1203968
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
BRCA1 and BRCA2 are breast cancer susceptibility genes. Mutations within BRCA1 and BRCA1 are responsible for most familial breast cancer cases. Targeted deletion of Brca1 or Brca2 in mice has revealed an essential function for their encoded products, BRCA1 and BRCA2, in cell proliferation during embryogenesis. Mouse models established from conditional expression of mutant Brca1 alleles develop mammary gland tumors, providing compelling evidence that BRCA1 functions as a breast cancer suppressor. Human cancer cells and mouse cells deficient in BRCA1 or BRCA2 exhibit radiation hypersensitivity and chromosomal abnormalities, thus revealing a potential role for both BRCA1 and BRCA2 in the maintenance of genetic stability through participation in the cellular response to DIVA damage. Functional analyses of the BRCA1 and BRCA2 gene products have established their dual participation in transcription regulation and DNA damage repair. Potential insight into the molecular basis for these functions of BRCA1 and BRCA2 has been provided by studies that implicate these two tumor suppressors in both the maintenance of genetic stability and the regulation of cell growth and differentiation.
引用
收藏
页码:6159 / 6175
页数:17
相关论文
共 50 条
  • [31] The Contribution of BRCA1 and BRCA2 to Ovarian Cancer
    Ramus, Susan J.
    Gayther, Simon A.
    MOLECULAR ONCOLOGY, 2009, 3 (02) : 138 - 150
  • [32] The role of BRCA1 and BRCA2 in prostate cancer
    Castro, Elena
    Eeles, Rosalind
    ASIAN JOURNAL OF ANDROLOGY, 2012, 14 (03) : 409 - 414
  • [33] The role of BRCA1 and BRCA2 in prostate cancer
    Li, Dan
    Kumaraswamy, Easwari
    Harlan-Williams, Lisa M.
    Jensen, Roy A.
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2013, 18 : 1445 - 1459
  • [34] Population screening for BRCA1/BRCA2 mutations: lessons from qualitative analysis of the screening experience
    Lieberman, Sari
    Lahad, Amnon
    Tomer, Ariela
    Cohen, Carmit
    Levy-Lahad, Ephrat
    Raz, Aviad
    GENETICS IN MEDICINE, 2017, 19 (06) : 628 - 634
  • [35] BRCA1 and BRCA2 Mutations in Ovarian Cancer
    Buerkle, Bernd
    Tempfer, Clemens
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2012, 307 (04): : 359 - 359
  • [36] BRCA1 and BRCA2 Mutations and Breast Cancer
    Narod, Steven A.
    Salmena, Leonardo
    DISCOVERY MEDICINE, 2011, 12 (66) : 445 - 453
  • [37] Characterization of common BRCA1 and BRCA2 variants
    Deffenbaugh, AM
    Frank, TS
    Hoffman, M
    Cannon-Albright, L
    Neuhausen, SL
    GENETIC TESTING, 2002, 6 (02): : 119 - 121
  • [38] BRCA1 and BRCA2 in hereditary breast cancer
    Scully, R
    Puget, N
    BIOCHIMIE, 2002, 84 (01) : 95 - 102
  • [39] Usefulness of BRCA1 and BRCA2 testing questioned
    Bradbury, J
    LANCET, 1997, 349 (9064): : 1524 - 1524
  • [40] Cancer susceptibility and the functions of BRCA1 and BRCA2
    Venkitaraman, AR
    CELL, 2002, 108 (02) : 171 - 182